1. Home
  2. NUVL vs CAG Comparison

NUVL vs CAG Comparison

Compare NUVL & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$99.24

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Logo ConAgra Brands Inc.

CAG

ConAgra Brands Inc.

HOLD

Current Price

$19.03

Market Cap

8.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
CAG
Founded
2017
1919
Country
United States
United States
Employees
N/A
26100
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.9B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
NUVL
CAG
Price
$99.24
$19.03
Analyst Decision
Strong Buy
Hold
Analyst Count
15
14
Target Price
$135.33
$19.50
AVG Volume (30 Days)
443.1K
11.3M
Earning Date
01-01-0001
03-19-2026
Dividend Yield
N/A
7.52%
EPS Growth
N/A
233.33
EPS
N/A
N/A
Revenue
N/A
$1,500,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,064.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$55.54
$15.96
52 Week High
$113.02
$28.52

Technical Indicators

Market Signals
Indicator
NUVL
CAG
Relative Strength Index (RSI) 42.84 53.66
Support Level $98.65 $18.98
Resistance Level $107.13 $19.55
Average True Range (ATR) 4.05 0.55
MACD -0.31 -0.08
Stochastic Oscillator 19.28 46.60

Price Performance

Historical Comparison
NUVL
CAG

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About CAG ConAgra Brands Inc.

Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.

Share on Social Networks: